Breakthrough Chemistry, Inc.

Breakthrough Chemistry, Inc.

BKTH
Breakthrough Chemistry, Inc.US flagOther OTC
0.28
USD
+0.00
- -
2.69MMarket Cap
Breakthrough Chemistry, Inc.
BKTH
(Other OTC)

Recent

price

0.28

P/E

ratio

- -

div

yld

- -

ROIC.AI

2003
2004
2005
2006
2007
2008
2009
2010
TTM
FRC
360.07
600.79
1,530.33
1,481.65
429.31
35.34
479.56
69.74
16.37
Revenue per Share
-1,660.84
-6,044.05
-2,077.51
-1,712.58
-1,146.67
-521.24
-239.49
-405.06
-80.61
Basic EPS, GAAP
-925.38
-932.97
-333.65
-305.07
-587.43
-459.8
-341.66
-45.91
-1.99
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-2,714.66
-1,712.91
-7,388.93
-8,566.25
-7,786.75
-5,375.84
-5,417.99
-1,614.21
-355.34
Book Value per Share
-1,284.4
-562.93
319.73
-322.55
-694.32
-953.42
184.47
-31.78
-5.18
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
1
1
- -
- -
1
- -
- -
Sales/Revenue/Turnover
-461.25
-895.73
-94.59
-99.35
-257.24
-1,423.51
-45.31
-191.88
-134.03
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-2
-1
-1
-1
-1
- -
-2
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-461.25
-1,006.01
-135.76
-115.59
-267.1
-1,474.97
-49.94
-580.85
-492.39
Profit Margin (%)
- -
- -
- -
- -
- -
-1
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
1
- -
- -
- -
LT Debt
- -
- -
- -
- -
1
- -
2
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Oct'11
Jan'11
Apr'11
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
1

Working Capital

FRC

in mil. unless spec.
Oct'11
Jan'11
Apr'11
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-133.87%
-109.82%
Free Cash Flow
- -
21.81%
-39.8%
Net Income, GAAP
- -
110.66%
657.79%
Sales/Revenue/Turnover
- -
228.03%
-34.85%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
1
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
-209.2
262.28
-130.11
- -
-239.49
2010
-264.38
-156.59
-292.43
- -
-405.06
2011
-4.51
-2.75
-1.72
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -
Business
Breakthrough Chemistry, Inc. (BKTH) engages in the development and commercialization of engineered chemical platforms designed to address safety, environmental, and performance challenges across multiple industries. The company operates three primary platforms: Stabilized Halogen Oxidizers for odor destruction and VOC reduction with antimicrobial attributes; Silicon Dioxide (SiO₂) Surface Protection Coatings for glass, polymeric, automotive, marine, aviation, and industrial surfaces; and Fire Inhibitor Mineral Platforms for building materials, foams, textiles, carpets, composites, and engineered plastics. BKTH positions these platforms for applications in agriculture, transportation, household and commercial care, construction, industrial materials, sports safety, and environmental markets, with a focus on scalable, certifier-friendly solutions and measurable performance. Founding year and headquarters: BKTH is headquartered in Bonita Springs, Florida, United States. The company is publicly traded on the OTC Markets under ticker BKTH and maintains a strategic focus on expanding its global presence, licensing opportunities, and partnerships to accelerate adoption of its chemistry platforms. BKTH reports a commitment to clean, engineered chemistry with scalable, certified-backed innovations and aims to grow revenue through licensing, collaborations, and international expansion. Latest major company changes include recent partnerships and strategic alliances, funding activity, and product development milestones intended to broaden geographic reach and market penetration. The company emphasizes ongoing expansion across North America and the Indo-Pacific region, pursuing licensing, strategic partnerships, and targeted international growth to monetize its platform technologies. BKTH communicates a focus on operational scale-up, market expansion, and the advancement of its three platform families into additional verticals and geographic regions through collaboration and alliance strategies. Industry and business segments BKTH operates within the Pharmaceuticals and Specialty Chemicals space, with business segments centered on platform-based chemical innovations, regulatory-compliant product development, and contract licensing. Target customers include industrial manufacturers, consumer product companies, and service providers seeking advanced odor control, surface protection, and fire-inhibition technologies. Geographic operations are global, with a stated emphasis on expansion into Asia-Pacific and North American markets, and a presence in the United States. Subsidiaries or parent company relationships are not clearly disclosed in the available information.